Ideas to action: independent research for global prosperity
Global Fund
More from the Series
Blog Post
March 05, 2013
Amid an increasingly complex fiscal environment in Washington (i.e. the newly-triggered sequester and the soon-to-expire FY13 continuing resolution), I can’t help but think about the tough trade-offs the Office of Management and Budget (OMB) must be considering as they finalize the President’s FY14 ...
Blog Post
November 12, 2012
This week the Global Fund Board will determine whether to “expand, accelerate, terminate or suspend the Affordable Medicines Facility – malaria (AMFm).” Ideally, the Board would make an evidence-based decision. However, both the sufficiency and the relevance of available technical evidence have been...
Blog Post
November 08, 2012
This is a joint post with Heather Lanthorn.
The Global Fund Board’s decision over the Affordable Medicines Facility – malaria (AMFm) rapidly approaches, and tensions within the malaria community are acute. In her global health blog for The Guardian, Sarah Boseley characterizes the rift as one...
Blog Post
September 21, 2012
As the Global Fund’s November board meeting approaches – where the future of the Affordable Medicines Facility for Malaria (AMFm) hangs in the balance – there is much anxiety that AMFm will be terminated in 2013. The reason for such anxiety is clear: no donors have pledged funding commitments for af...
Blog Post
September 11, 2012
There’s an AIDS spending cliff in Ethiopia and the government is already in free fall. Next year, Ethiopia will experience a 79% reduction in US HIV financing from PEPFAR. The announcement of these cuts came with an explanation that PEPFAR was “free(ing) up resources by reducing programs in lower HI...